The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Open accessAbstract
The gene encoding latent-infection membrane protein 1 (LMP1) was specifically mutated in Epstein-Barr virus (EBV) recombinants by inserting a nonsense linker after codon 9 or codon 84 or into an intron 186 bp 3' to the latter insertion site. EBV recombinants with the LMP1 intron mutation were wild type for LMP1 expression and for growth transformation of primary B lymphocytes. In contrast, EBV recombinants with the mutations in the LMP1 open reading frame expressed N-terminally truncated crossreactive proteins and could initiate or maintain primary B-lymphocyte transformation only when wild-type LMP1 was provided in trans by a coinfecting, transformation-defective EBV, P3HR-1. These data indicate that LMP1 is essential for EBV-mediated transformation of primary B lymphocytes, that the first 43 amino acids are critical for LMP1's function, and that codon 44-initiated LMP1 does not have a dominant negative effect on transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Wang, D., Liebowitz, D., & Kieff, E. (1985) · Cell · doi:10.1016/0092-8674(85)90256-9 · Cited by 1,225
Self-citationHenderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., & Rickinson, A. (1991) · Cell · doi:10.1016/0092-8674(91)90007-l · Cited by 1,168
Self-citationYoung, L., Alfieri, C., Hennessy, K., Evans, H., O'Hara, C., Anderson, K. C., Ritz, J., Shapiro, R. S., Rickinson, A., Kieff, E., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910193211604 · Cited by 749
Self-citationGenetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes
Hammerschmidt, W., & Sugden, B. (1989) · Nature · doi:10.1038/340393a0 · Cited by 541
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Cohen, J. I., Wang, F., Mannick, J., & Kieff, E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9558 · Cited by 483
Self-citationTomkinson, B., Robertson, E., & Kieff, E. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2014-2025.1993 · Cited by 388
Self-citationWang, D., Liebowitz, D., Wang, F., Gregory, C. D., Rickinson, A. B., Larson, R. A., Springer, T. A., & Kieff, E. D. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4173-4184.1988 · Cited by 384
Self-citationEpstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.
Herbst, H., Dallenbach, F., Hummel, M., Niedobitek, G., Pileri, S., Müller-Lantzsch, N., & Stein, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4766 · Cited by 383
Cited by
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Mosialos, G., Birkenbacht, M., Yalamanchill, R., Van Arsdale, T., Ware, C., & Kleff, E. (1995) · Cell · doi:10.1016/0092-8674(95)90489-1 · Cited by 980
Epstein–Barr virus: more than 50 years old and still providing surprises
Young, L. S., Yap, L. F., & Murray, P. G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.92 · Cited by 856
Cytokine therapeutics: lessons from interferonalpha.
Gutterman, J. U. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1198 · Cited by 703
Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K., & Raab-Traub, N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331103 · Cited by 620
Molyneux, E. M., Rochford, R., Griffin, B., Newton, R., Jackson, G., Menon, G., Harrison, C. J., Israels, T., & Bailey, S. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61177-x · Cited by 613
Epstein–Barr virus and oncogenesis: from latent genes to tumours
Young, L. S., & Murray, P. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206556 · Cited by 556
Human tumor virus utilizes exosomes for intercellular communication
Meckes, D. G., Shair, K. H. Y., Marquitz, A. R., Kung, C.-P., Edwards, R. H., & Raab-Traub, N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014194107 · Cited by 541
Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data
Glaser, S. L., Lin, R. J., Stewart, S. L., Ambinder, R. F., Jarrett, R. F., Brousset, P., Pallesen, G., Gulley, M. L., Khan, G., O'Grady, J., et al. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970207)70:4<375::aid-ijc1>3.0.co;2-t · Cited by 506
Devergne, O., Hatzivassiliou, E., Izumi, K. M., Kaye, K. M., Kleijnen, M. F., Kieff, E., & Mosialos, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.7098 · Cited by 491
Self-citationKilger, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1700 · Cited by 483
Propagation and recovery of intact, infectious Epstein–Barr virus from prokaryotic to human cells
Delecluse, H.-J., Hilsendegen, T., Pich, D., Zeidler, R., & Hammerschmidt, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8245 · Cited by 467
Latent membrane protein 1of Epstein-Barr virus mimics a constitutively active receptor molecule
Gires, O. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6131 · Cited by 451
Walsh, M. C., Lee, J., & Choi, Y. (2015) · Immunological Reviews · doi:10.1111/imr.12302 · Cited by 438
Mimicry of CD40 Signals by Epstein-Barr Virus LMP1 in B Lymphocyte Responses
Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N., & Kikutani, H. (1999) · Science · doi:10.1126/science.286.5438.300 · Cited by 437
Kulwichit, W., Edwards, R. H., Davenport, E. M., Baskar, J. F., Godfrey, V., & Raab-Traub, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11963 · Cited by 414
Izumi, K. M., & Kieff, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12592 · Cited by 394
Self-citationMicrovesicles and Viral Infection
Meckes, D. G., & Raab-Traub, N. (2011) · Journal of Virology · doi:10.1128/jvi.05853-11 · Cited by 390
Epstein–Barr virus latent genes
Kang, M.-S., & Kieff, E. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.84 · Cited by 361
Self-citationNanbo, A., Kawanishi, E., Yoshida, R., & Yoshiyama, H. (2013) · Journal of Virology · doi:10.1128/jvi.01310-13 · Cited by 355
Latent membrane protein 1of Epstein-Barr virus interacts with JAK3 and activates STAT proteins
Gires, O. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3064 · Cited by 350
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
Wilson, J. B., Bell, J. L., & Levine, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00674.x · Cited by 334
The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma
Park, S., Lee, J., Ko, Y. H., Han, A., Jun, H. J., Lee, S. C., Hwang, I. G., Park, Y. H., Ahn, J. S., Jung, C. W., et al. (2007) · Blood · doi:10.1182/blood-2007-01-067769 · Cited by 320
Miller, C. L., Burkhardt, A. L., Lee, J. H., Stealey, B., Longnecker, R., Bolen, J. B., & Kieff, E. (1995) · Immunity · doi:10.1016/s1074-7613(95)80040-9 · Cited by 320
Self-citationKieser, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6478 · Cited by 319
Smatti, M. K., Al-Sadeq, D. W., Ali, N. H., Pintus, G., Abou-Saleh, H., & Nasrallah, G. K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00211 · Cited by 309
Mitchell, T., & Sugden, B. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2968-2976.1995 · Cited by 273
Epstein-Barr Virus Provides a New Paradigm: A Requirement for the Immediate Inhibition of Apoptosis
Altmann, M., & Hammerschmidt, W. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030404 · Cited by 266
Miller, C. L., Lee, J. H., Kieff, E., & Longnecker, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.772 · Cited by 257
Self-citationFries, K. L., Miller, W. E., & Raab-Traub, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8653-8659.1996 · Cited by 255
Sugimoto, M., Tahara, H., Ide, T., & Furuichi, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0079 · Cited by 149
Sylla, B. S., Hung, S. C., Davidson, D. M., Hatzivassiliou, E., Malinin, N. L., Wallach, D., Gilmore, T. D., Kieff, E., & Mosialos, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10106 · Cited by 137
Self-citationLiang, J., Zhou, H., Gerdt, C., Tan, M., Colson, T., Kaye, K. M., Kieff, E., & Zhao, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616697113 · Cited by 88
Self-citationYang, X., He, Z., Xin, B., & Cao, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203515 · Cited by 71
Metadata
- Authors
- Kaye, K. M., Izumi, K. M., & Kieff, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-10
- Volume
- 90
- Issue
- 19
- Pages
- 9150-9154
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2079199354
- Cited by
- 762
- References
- 24
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.